Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military (2002) Medical Follow-Up Agency (MFUA), Institute of Medicine (IOM)

	Openbook Linked Table of ContentsFront Matter, pp. i-xxivExecutive Summary, pp. 1-81 Introduction and History, pp. 9-192 Resources, Responsibilities, and ..., pp. 20-383 Current Status of Vaccines for Mi..., pp. 39-544 Recommendations with Accompanying..., pp. 55-94References, pp. 95-104Appendix A: Reprint of the commite..., pp. 105-118Appendix B: Open Meeting Agendas, pp. 119-126Appendix C: Committee and Staff Bi..., pp. 127-134

---

Please note that the searchable text is scanned, uncorrected text, and should be presumed inaccurate. The page images should be used as the authoritative version.

Hits were found on pages 41, 42, 43, 44, 51 A total of 16 pages of uncorrected, machine-read text were searched. 5 pages were identified which contain a total of 8 lines that match "smallpox vaccine."

---

At the bottom of

PAGE 41

DHHS initially contracted OraVax (now a part of Acambis, Inc.) to produce 50 million doses of a cell culture smallpox vaccine (Acambis, Inc., 2000). After the events of September 11, 2001, and the anthrax mailings in October 2001, the Department of Health and Human Services expanded its

At the bottom of

PAGE 41

contract. The $428 million contract with Acambis, Inc. (and its subcontractor, Baxter International), is to produce 155 million additional doses of the smallpox vaccine (DHHS, 2001). DynPort Vaccine Corporation, DoD's prime vendor contractor through the Joint Vaccine Acquisition Program, has

At the bottom of

PAGE 41

Corporation, DoD's prime vendor contractor through the Joint Vaccine Acquisition Program, has linked with BioReliance to produce 300,000 doses of a smallpox vaccine (Brownlee, 2001; Johnson- Winegar, 2001).

At the bottom of

PAGE 41

be at risk for smallpox, and in such cases arrangements must be made to transfer the smallpox vaccine from the Centers for Disease Control and Prevention (CDC)

At the bottom of

PAGE 42

1DynPort Vaccine Corporation, DoD's prime vendor contractor through the Joint Vaccine Acqui- sition Program, has linked with BioReliance to produce a smallpox vaccine. The vaccine is being evaluated at the University of Kentucky, and Phase I clinical trials began in April 2002 (Gay, 2002;

At the bottom of

PAGE 43

Rubella virus vaccine, live, attenuated Smallpox vaccines Tetanus and diphtheria toxoid, adsorbed

At the top of

PAGE 44

Plague vaccine Smallpox vaccine Previously manufactured by Wyeth Vaccines

On

PAGE 51

Botulinum pentavalent toxoid 1979 1995 Smallpox vaccine (DryvaxO) 2001 1982 NOTE: The army also has a separate IND application (Army BB-IND #3723) on file for botulinum